Michael O. Idowu, MB is an expert in the field of Pathology. Michael O. Idowu, MB is a published doctor as well. He has 33 publications published. The latest was: A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688. He accepts Medicare payments and is listed with Medicare.gov.
Virginia Commonwealth University Health System
Memorial Sloan-Kettering Cancer Center
University of Ibadan| National Provider Identifier [NPI] | 1962413310 |
| Last Name Of The Provider | IDOWU |
| First Name Of The Provider | MICHAEL |
| View All |
|
Dr. Sarah E. Gibson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sukru S. Demirci, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Adele O. Kraft, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Enrique Gerszten, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Yasmin I. Lutterbie, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David M. Capuzzi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrea G. Jelinek, DO |
|
Dr. Austin B. Wiles, MD
This Doctor is OpenDoctor Recommended.
|
|
Dipti A. Surve, MB BS
This Doctor is OpenDoctor Recommended.
|